Literature DB >> 16641580

Exocrine pancreatic function in children with progressive familial intrahepatic cholestasis type 2.

Jaroslaw Walkowiak1, Irena Jankowska, Joanna Pawlowska, Sandra Strautnieks, Laura Bull, Richard Thompson, Karl-Heinz Herzig, Jerzy Socha.   

Abstract

In progressive familial intrahepatic cholestasis type 2 (PFIC-2), severe steatorrhea is often documented. However, pancreatic exocrine secretion has not yet been studied. In 14 children with PFIC-2, pancreatic function was assessed using standard fecal tests. Normal fecal lipase concentrations excluded isolated lipase deficiency. No differences in fecal elastase-1 concentrations and chymotrypsin activities were detected between PFIC-2 patients with or without steatorrhea, nor between these patients and healthy subjects. In conclusion, pancreatic exocrine function in patients with PFIC-2 is normal. Steatorrhea observed in those patients is not related to pancreatic insufficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641580     DOI: 10.1097/01.mpg.0000218154.26792.6a

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  Differences in presentation and progression between severe FIC1 and BSEP deficiencies.

Authors:  Ludmila Pawlikowska; Sandra Strautnieks; Irena Jankowska; Piotr Czubkowski; Karan Emerick; Anthony Antoniou; Catherine Wanty; Bjorn Fischler; Emmanuel Jacquemin; Sami Wali; Samra Blanchard; Inge-Merete Nielsen; Billy Bourke; Shirley McQuaid; Florence Lacaille; Jane A Byrne; Albertien M van Eerde; Kaija-Leena Kolho; Leo Klomp; Roderick Houwen; Peter Bacchetti; Steven Lobritto; Vera Hupertz; Patricia McClean; Giorgina Mieli-Vergani; Benjamin Shneider; Antal Nemeth; Etienne Sokal; Nelson B Freimer; A S Knisely; Philip Rosenthal; Peter F Whitington; Joanna Pawlowska; Richard J Thompson; Laura N Bull
Journal:  J Hepatol       Date:  2010-04-13       Impact factor: 25.083

2.  Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption.

Authors:  Atul R Chopra; Ramakrishna Kommagani; Pradip Saha; Jean-Francois Louet; Christina Salazar; Junghun Song; Jaewook Jeong; Milton Finegold; Benoit Viollet; Franco DeMayo; Lawrence Chan; David D Moore; Bert W O'Malley
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

3.  Phenotypic and Molecular Characteristics of Children with Progressive Familial Intrahepatic Cholestasis in South China.

Authors:  Wen Zhang; Ruizhu Lin; Zhikun Lu; Huiying Sheng; Yi Xu; Xiuzhen Li; Jing Cheng; Yanna Cai; Xiaojian Mao; Li Liu
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-11-05

4.  Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis.

Authors:  Lee M Bass; Deepa Patil; M Sambasiva Rao; Richard M Green; Peter F Whitington
Journal:  BMC Gastroenterol       Date:  2010-03-13       Impact factor: 3.067

Review 5.  Clinical application of transcriptional activators of bile salt transporters.

Authors:  Anna Baghdasaryan; Peter Chiba; Michael Trauner
Journal:  Mol Aspects Med       Date:  2013-12-12

6.  Exocrine pancreatic function in children with Alagille syndrome.

Authors:  Dorota Gliwicz; Irena Jankowska; Aldona Wierzbicka; Anna Miśkiewicz-Chotnicka; Aleksandra Lisowska; Jarosław Walkowiak
Journal:  Sci Rep       Date:  2016-10-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.